Category: Oral MS Medications

How much does your neurologist know of ‘soon coming’ oral MS therapies such as Gilenia (FTY720)?

Surveyed Neurologists’ Awareness of Merck Serono/EMD Serono’s Oral Cladribine is Double that of Novartis/Mitsubishi Tanabe’s FTY-720 (Gilenia) Posted on: Thursday,…

Stuart Schlossman

Merck Serono’s Cladribine Tablets for MS Approved in Russia, Under the Trade Name Movectro(R)

GENEVA, July 12, 2010 /PRNewswire/ — – First Approval Ever of an Oral Disease-modifying Therapy for Multiple Sclerosis – Cladribine…

Stuart Schlossman

Research News on Oral MS Therapies

 The National MS Society and MS LEARN ONLINE present… Research News on Oral Therapies A new Feature Presentation:   Research News…

Stuart Schlossman

German pharmaceuticals and chemicals company Merck KGaA is banking on an experimental multiple sclerosis (MS) pill to lift operating margins

(Reuters) – German pharmaceuticals and chemicals company Merck KGaA is banking on an experimental multiple sclerosis (MS) pill to lift…

Stuart Schlossman

The Orals are Coming. The Orals Are Coming – Will You Switch to an Oral MS Drug?

June 15, 2010 Written By Julie Stachowiak, Ph.D., It looks like the time when oral MS drugs will be available…

Stuart Schlossman

FDA Panel Recommends Approval of Oral Fingolimod for Relapsing MS

Jun 10, 2010 FDA Panel Recommends Approval of Oral Fingolimod for Relapsing MS — If agency follows advice, it would…

Stuart Schlossman

Novartis Gains Support for First Pill to Treat Multiple Sclerosis

By Catherine Larkin June 10 (Bloomberg) — Novartis AG won a U.S. panel’s backing to introduce the first pill to…

Stuart Schlossman

“CONCERNED” – FDA staff eyes safety of Novartis’ MS drug

(Reuters) – U.S. regulators expressed concern about potential side effects of Novartis AG’s multiple sclerosis pill in patients most at…

Stuart Schlossman

New Data Suggest Oral Laquinimod May Confer Neuroprotection in Addition to Immunomodulation in the Treatment of Multiple Sclerosis

Press Release Source: Active Biotech On Thursday April 15, 2010, 12:50 pm LUND, SWEDEN–(Marketwire – 04/15/10) – – Enhanced levels…

Stuart Schlossman

Teva to Present New Data on Multiple Sclerosis and Parkinson’s Disease at the 62nd American Academy of Neurology Annual Meeting

ress Release Source: Teva Pharmaceutical Industries Ltd. On Wednesday April 7, 2010, 10:45 am EDT JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd.…

Stuart Schlossman

Categories

Latest Blog Posts